Human breast tissue tests link reduced amounts of mitochondrial DNA content with a greater incidence of metastatic breast cancer.
Cancer and Genetics
New Medical Guidelines for Cervical Cancer Screening: Is there a role for new molecular diagnostics?
Some may argue that the new ACOG, ACS and other cervical cancer screening guidelines will detect the majority of at-risk women. We should not be content with settling for identifying a majority of at risk women; rather, we should constantly reassess the availability of useful tests to see if we can improve reliability.
Premenopausal women who schedule regular mammograms may benefit by undergoing screening during the first week of their menstrual cycle, according to research published in the February issue of Radiology.
In women with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer, treatment with trastuzumab for one year after chemotherapy is associated with significant disease-free survival at a four-year follow-up, according to a study published online Feb. 25 in The Lancet Oncology.